Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study
about
The role of calprotectin in pediatric diseaseJuvenile Idiopathic Arthritis: Diagnosis and TreatmentUveitis in juvenile idiopathic arthritisThe neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab.IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.Comprehensive protein profiling of synovial fluid in osteoarthritis following protein equalization.MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis.S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever.Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.Limits of Peripheral Blood Mononuclear Cells for Gene Expression-Based Biomarkers in Juvenile Idiopathic Arthritis.S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis.Current developments in the use of biomarkers for juvenile idiopathic arthritis.Biomarkers of cartilage and surrounding joint tissue.Understanding inflammation in juvenile idiopathic arthritis: How immune biomarkers guide clinical strategies in the systemic onset subtype.High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.Enhancing translational research in paediatric rheumatology through standardization.Correlation of Secretory Activity of Neutrophils With Genotype in Patients With Familial Mediterranean Fever.P03-022 - Calprotec in chronic nonbacterial osteomyelitis.A Non-Peptidic S100A9 Specific Ligand for Optical Imaging of Phagocyte Activity In Vivo.S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis.S100A12 levels in synovial fluid may reflect clinical severity in patients with primary knee osteoarthritis.Low pretreatment levels of myeloid-related protein-8/14 and C-reactive protein predict poor adherence to treatment with tumor necrosis factor inhibitors in juvenile idiopathic arthritis.Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what?MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis.Transcription factor motif enrichment in whole transcriptome analysis identifies STAT4 and BCL6 as the most prominent binding motif in systemic juvenile idiopathic arthritis.Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study.Validation of Relapse Risk Biomarkers for Routine Use in Patients With Juvenile Idiopathic ArthritisA Granulocyte-Specific Protein S100A12 as a Potential Prognostic Factor Affecting Aggressiveness of Therapy in Patients with Juvenile Idiopathic Arthritis
P2860
Q26852795-D3AF1C62-39F2-4FA7-872C-CDA754229126Q28079246-CE46EA3E-A9DB-4200-8CF5-AC47746E4392Q28086972-C220E757-B76C-4FD4-8259-91DCD5C870F1Q34333827-109B4D62-4890-4D46-AA49-81030235B28AQ35291353-B6E2E221-F963-4E34-97F5-839D3BBF025DQ35925645-1146D751-89B3-47D1-8B57-D7A2534FA50CQ35926593-83E80149-85F9-48B0-9905-C94661495DEAQ36007812-54E0994A-490A-46B5-867B-F6E090781FE2Q36266841-CA54A873-B3B9-445A-806A-A81BFDC95443Q37072649-181A5DE1-50E6-4CB4-95F9-0AB1BFA43B6BQ37364345-773E0986-E9FE-4E37-8BCD-DC999CB8C03FQ37595918-B28516C2-08EC-4DFF-861D-69C8469B2EA0Q38239828-5602585B-386F-4685-855F-F3A8EB930FF8Q38909520-D791136F-FD62-4689-831A-DA783855C172Q38913955-0095EE39-2AB5-4617-AEDB-BB3A8F4C24B1Q38960512-F3C095D6-CD41-4FE2-9360-DFD1112C8845Q40100206-950FA8CD-EFFD-4D4F-A1F5-B69B7CA46DB4Q46056755-F80F9ABE-F303-4E1D-AD2F-58F7D61B6C0BQ48219566-8328E760-6DD4-4737-93AC-C205AEC922BDQ48262195-652D7FC7-751F-4CD6-8A4C-08066DC8D57CQ50861824-4B21B1BA-416C-4CFC-BB41-FC21DAD1A47EQ51550151-B37E69BD-DA47-419B-9216-4CE61865F0CDQ53071375-FF1B65AA-6E41-4745-8BC1-E22B1F463D80Q54501729-65D96B59-37C5-4E6C-BCCA-DFE438456CF9Q54945619-4B9AE8A1-0608-4F8D-AD33-3B31E815B113Q55023560-4D188C88-934A-48E6-A6FD-33B8C1520C21Q57913847-8470EFAD-16CF-4881-BE15-38D1694DF62AQ58694039-309DE4EF-D563-41FA-B552-3C4CCC2BBED3
P2860
Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study
description
im Juni 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 11 June 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2012
@uk
name
Phagocyte-specific S100 protei ...... arthritis: a comparative study
@en
Phagocyte-specific S100 protei ...... arthritis: a comparative study
@nl
type
label
Phagocyte-specific S100 protei ...... arthritis: a comparative study
@en
Phagocyte-specific S100 protei ...... arthritis: a comparative study
@nl
prefLabel
Phagocyte-specific S100 protei ...... arthritis: a comparative study
@en
Phagocyte-specific S100 protei ...... arthritis: a comparative study
@nl
P2093
P50
P1476
Phagocyte-specific S100 protei ...... arthritis: a comparative study
@en
P2093
Alberto Martini
Claudia Toppino
Claudio Len
Dimitrina Mihaylova
Dirk Foell
Erbil Unsal
Helmut Wittkowski
Henryka Mazur-Zielinska
Joachim Gerss
Johannes Roth
P304
P356
10.1136/ANNRHEUMDIS-2012-201329
P407
P577
2012-06-11T00:00:00Z